IVERIC bio Investor Relations Material
Latest events
Q4 2022
IVERIC bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IVERIC bio Inc
Access all reports
IVERIC bio, Inc. is a biopharmaceutical company specializing in the discovery and development of treatments for retinal diseases. The company's focus includes developing therapies for age-related macular degeneration and other ocular conditions that lead to vision loss. IVERIC bio aims to address unmet medical needs in ophthalmology through innovative research and targeted approaches to eye health. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
ISEE
Country
🇺🇸 United States